Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
ONCT-808
i
Other names:
ONCT-808, ROR1 CAR T-cell therapy, ONCT 808, ONCT808
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(1)
News
Trials
Company:
Ho’ola Therapeutics, Oncternal Therap
Drug class:
ROR1-targeted CAR-T immunotherapy
Related drugs:
‹
LYL797 (2)
BMS-986403 (0)
JCAR024 (0)
LYL119 (0)
PRGN-3007 (0)
RD14-01 (0)
LYL797 (2)
BMS-986403 (0)
JCAR024 (0)
LYL119 (0)
PRGN-3007 (0)
RD14-01 (0)
›
Associations
(1)
News
Trials
VERI cancer hierarchy
Reset Filters
ROR1 overexpression
Mantle Cell Lymphoma
ROR1 overexpression
Mantle Cell Lymphoma
ONCT-808
Sensitive: D – Preclinical
ONCT-808
Sensitive
:
D
ONCT-808
Sensitive: D – Preclinical
ONCT-808
Sensitive
:
D
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.